van den Berg R H, Faber-Krol M C, van de Klundert J A, van Es L A, Daha M R
Department of Nephrology, University Hospital, Leiden, The Netherlands.
J Immunol. 1996 Jun 1;156(11):4466-73.
Molecular mimicry is a well established mechanism via which bacteria protect themselves from complement-mediated killing. We have previously demonstrated that a number of human cells express receptors for C1q (C1qR) and that the soluble form of this receptor inhibits activation of the classical pathway of complement. We now investigated whether Escherichia coli possesses a C1qR-like protein that protects these bacteria from complement-mediated injury. By FACS analysis it was shown that approximately 60% of the bacteria bound C1q directly in the absence of Abs. With ELISA we confirmed that the bacterial cell envelope was able to bind C1q in a dose-dependent fashion. We isolated a cell envelope associated C1q binding protein (C1qBP) by C1q affinity chromatography, then by anion exchange chromatography and gel filtration chromatography. On SDS-PAGE, the m.w. of C1qBP appeared to be 57 kDa and 51 kDa under reducing and nonreducing conditions, respectively. It was demonstrated that C1qBP specifically binds C1q and inhibits the hemolytic activity of C1q in both a dose- and time-dependent fashion. The binding of C1qBP to C1q is inhibited by C1q itself and also by the collagen-like stalks and the globular heads of C1q. In this respect, bacterial C1qBP is different from human C1qR because the binding of C1q to C1qR is only inhibited by the collagen-like stalks of C1q and not by the globular heads of C1q. C1qBP, when bound to C1q, prevents the assembly with C1r and C1s to form a functional C1 complex. The occurrence of C1qBP is not limited to certain E. coli strains, but is also found on Staphylococcus aureus, Citrobacter freundii, and Pseudomonas aeruginosa. Also, the binding of 125(I)-labeled C1q to these bacteria is specific because the binding of C1q to these bacteria is inhibitable with isolated soluble C1qBP. These findings provide evidence for the existence of a C1qR-like protein on bacteria that might protect them from complement-mediated damage.
分子模拟是一种已被充分证实的机制,细菌可借此保护自身免受补体介导的杀伤。我们之前已经证明,许多人类细胞表达C1q受体(C1qR),且该受体的可溶性形式可抑制补体经典途径的激活。我们现在研究了大肠杆菌是否拥有一种类似C1qR的蛋白,该蛋白可保护这些细菌免受补体介导的损伤。通过流式细胞术分析表明,在没有抗体的情况下,约60%的细菌直接结合C1q。通过酶联免疫吸附测定我们证实,细菌细胞膜能够以剂量依赖的方式结合C1q。我们通过C1q亲和层析,然后通过阴离子交换层析和凝胶过滤层析分离出一种与细胞膜相关的C1q结合蛋白(C1qBP)。在十二烷基硫酸钠-聚丙烯酰胺凝胶电泳上,在还原和非还原条件下,C1qBP的分子量分别似乎为57 kDa和51 kDa。结果表明,C1qBP以剂量和时间依赖的方式特异性结合C1q并抑制C1q的溶血活性。C1qBP与C1q的结合受到C1q自身以及C1q的胶原样茎和球状头部的抑制。在这方面,细菌C1qBP与人类C1qR不同,因为C1q与C1qR的结合仅受到C1q的胶原样茎的抑制,而不受C1q球状头部的抑制。当C1qBP与C1q结合时,可阻止其与C1r和C1s组装形成功能性C1复合物。C1qBP的存在并不局限于某些大肠杆菌菌株,在金黄色葡萄球菌、弗氏柠檬酸杆菌和铜绿假单胞菌中也有发现。此外,125(I)标记的C1q与这些细菌的结合是特异性的,因为C1q与这些细菌的结合可被分离的可溶性C1qBP抑制。这些发现为细菌上存在一种类似C1qR的蛋白提供了证据,该蛋白可能保护它们免受补体介导的损伤。